Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

Keyphrases

• AIDS/HIV 100%
• Antiretroviral 100%
• Osteonecrosis 100%
• Tenofovir Disoproxil Fumarate 50%
• Fracture Risk 37%
• Cumulative Exposure 25%
• Baseline CD4 25%
• White Race 25%
• Prior Fracture 25%
• Cardiovascular Disease 12%
• Poisson Regression 12%
• Old Age 12%
• Bone Mineral Density 12%
• Comorbidity 12%
• Bone Turnover 12%
• Human Immunodeficiency Virus Infection 12%
• Fracture Incidence 12%
• High Incidence 12%
• Clinical Laboratory 12%
• Virologically Suppressed 12%
• EuroSIDA 12%
• HCV Co-infection 12%
• CD4 Nadir 12%
• Virus-specific 12%
• Host Factors 12%
• Clinical Predictors 12%
• Low BMI 12%
• Both Bones 12%
• Demographic Predictors 12%
• Mutual Adjustment 12%
• IV Drug Use 12%
• Femoral Head Osteonecrosis 12%
• Independent Risk Factors 12%
• Non-AIDS Cancer 12%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Bone Necrosis 100%
• Tenofovir Disoproxil 50%
• Acquired Immune Deficiency Syndrome 25%
• Bone Density 12%
• Malignant Neoplasm 12%
• Body Mass Index 12%
• Cardiovascular Disease 12%
• Mixed Infection 12%
• Drug Use 12%
• Bone Turnover 12%
• Human Immunodeficiency Virus Infection 12%
• Host Factor 12%
• Osteonecrosis Of The Femoral Head 12%
• Comorbidity 12%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Bone Necrosis 100%
• Tenofovir Disoproxil 44%
• Acquired Immune Deficiency Syndrome 22%
• Malignant Neoplasm 11%
• Mixed Infection 11%
• Human Immunodeficiency Virus Infection 11%
• Host Factor 11%
• Comorbidity 11%
• Cardiovascular Disease 11%